Indication
Glioblastoma multiforme
Glioblastoma multiforme is a fast-growing, highly aggressive grade 4 central nervous system malignancy arising from supportive glial tissue, predominantly astrocytes. Read more about Glioblastoma multiforme
48 drugs 41 manufacturers
Drugs that treat it
Common Glioblastoma multiforme therapies.
ALYMSYS (bevacizumab-maly)
VEGZELMA (bevacizumab-adcd)
TEMOZOLOMIDE
TEMOZOLOMIDE
CARMUSTINE
CARMUSTINE
CARMUSTINE
CARMUSTINE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonGlioblastoma multiforme is a fast-growing, highly aggressive grade 4 central nervous system malignancy arising from supportive glial tissue, predominantly astrocytes.
It represents the most common primary malignant brain tumor in adults, primarily affecting the cerebral hemispheres and rarely the spinal cord.
Pathophysiologically, the tumor is characterized by poorly differentiated pleomorphic glial cells, brisk mitotic activity, prominent microvascular proliferation, and extensive areas of necrosis.
Clinically, its rapid growth and diffuse infiltration into surrounding brain parenchyma lead to progressive neurological deficits, seizures, and signs of elevated intracranial pressure, such as severe headaches and cognitive changes.
- cancer.gov
Glioblastoma multiforme is a fast-growing, highly aggressive grade 4 central nervous system malignancy arising from supportive glial tissue, predominantly astrocytes It represents the most common primary malignant brain tumor in adults, primarily affecting the cerebral hemispheres and rarely the spinal cord
- nih.gov
Glioblastoma multiforme is a fast-growing, highly aggressive grade 4 central nervous system malignancy arising from supportive glial tissue, predominantly astrocytes It represents the most common primary malignant brain tumor in adults, primarily affecting the cerebral hemispheres and rarely the spinal cord Pathophysiologically, the tumor is characterized by poorly differentiated pleomorphic glial cells, brisk mitotic activity, prominent microvascular proliferation, and extensive areas of necros...
- mayoclinic.org
Glioblastoma multiforme is a fast-growing, highly aggressive grade 4 central nervous system malignancy arising from supportive glial tissue, predominantly astrocytes Clinically, its rapid growth and diffuse infiltration into surrounding brain parenchyma lead to progressive neurological deficits, seizures, and signs of elevated intracranial pressure, such as severe headaches and cognitive changes
- youtube.com
Clinically, its rapid growth and diffuse infiltration into surrounding brain parenchyma lead to progressive neurological deficits, seizures, and signs of elevated intracranial pressure, such as severe headaches and cognitive changes
- ummhealth.org
Clinically, its rapid growth and diffuse infiltration into surrounding brain parenchyma lead to progressive neurological deficits, seizures, and signs of elevated intracranial pressure, such as severe headaches and cognitive changes
- stanfordhealthcare.org
Clinically, its rapid growth and diffuse infiltration into surrounding brain parenchyma lead to progressive neurological deficits, seizures, and signs of elevated intracranial pressure, such as severe headaches and cognitive changes
Personalize your experience
Follow Glioblastoma multiforme and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.